Previous close | 294.00 |
Open | 295.80 |
Bid | 285.70 x 100000 |
Ask | 286.60 x 100000 |
Day's range | 291.50 - 292.00 |
52-week range | 209.50 - 307.80 |
Volume | |
Avg. volume | 1 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 25 July 2024 - 29 July 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
HCA Healthcare's (HCA) quarterly results gain from broad volume-based growth along with a rising number of surgeries. Rising expenses act as a partial offset.
Robust Revenue Growth and Strategic Acquisitions Highlight the Quarter
While the top- and bottom-line numbers for HCA (HCA) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.